Joint Symposia
Hidenori Arai(National Center for Geriatrics and Gerontology., Japan)
KSoLA - JAS (Japan Atherosclerosis Society) : How to Develop New Guidelines for ASCVD in Asia | |||
---|---|---|---|
16:20-16:40 | Risk stratification of Japanese Patients with Dyslipidemia: Perspective for the Future ASCVD Guidelines ![]() |
![]() |
Yoshihiro Miyamoto National Cerebral and Cardiovascular Center, Japan |
16:40-17:00 | Current Status of Risk Factors and Prediction Models for Risk Stratification on ASCVD in Korea ![]() |
![]() |
Sung Hoon Yu Hanyang University, Korea |
17:00-17:20 | Lipid Management of Secondary Prevention in Japanese Population: Differences and Similarities Between East and West. ![]() |
![]() |
Hiroyuki Daida Juntendo University, Japan |
17:20-17:40 | New Treatment Guideline of Dyslipidemia in Korea ![]() |
![]() |
In-Kyung Jeong Kyung Hee University, Korea |
17:40-17:50 | Panel Discussion: Soo-Joong Kim, Cheol-Young Park, Jae Hyuk Lee, Sung Hee Choi |
Matsuzawa Yuji(Osaka University, Japan)
KSoLA - IAS (International Atherosclerosis Society) : Atherogenic TG and HDL Metabolism and Atherosclerosis | |||
---|---|---|---|
13:10-13:30 | PPAR gamma Phosphorylation and Metabolic Disease ![]() |
![]() |
Jang Hyun Choi UNIST, Korea |
13:30-13:50 | Roles of HDL and Cholesteryl Ester Transfer Protein in the Prevention of Atherosclerosis: Lesson from the Development of CETP Inhibitors and Subjects with CETP Deficiency ![]() |
![]() |
Yuji Matsuzawa Osaka University, Japan |
13:50-14:10 | Dietary Fat, Atherogenic Dyslipidemia and Cardiometabolic Health ![]() |
![]() |
Min-Jeong Shin Korea University, Korea |
14:10-14:30 | Impact of Pemafibrate for the Management of Dyslipidemia ![]() |
![]() |
Hidenori Arai National Center for Geriatrics and Gerontology, Japan |
14:30-14:40 | Panel Discussion: Chong Hwa Kim, Sang Yeub Lee, Soo Lim, Eun Gyoung Hong |
Ian M Graham(Trinity College, Ireland)
KSoLA – ESC (European Society of Cardiology) ; Atherosclerosis : New Target on LDL and Inflammation | |||
---|---|---|---|
15:50-16:10 | Basic Science Perspective; New Aspects of the Patho-biology of Atherosclerosis : The Role of Lipids & Inflammation ![]() |
![]() |
Alberico Catapano University of Milano, Italy |
16:10-16:30 | Identification of New Molecule to Mediate Binding of PCSK9 and LDL-Receptor -- New Insight on Action Mechanism of PCSK9 to Degrade LDL-R -- ![]() |
![]() |
Hyo-Soo Kim Seoul National University, Korea |
16:30-16:50 | Clinical Perspective: Current LDL-cholesterol Goals- Are They Appropriate? ![]() |
![]() |
Ian M. Graham Trinity College, Ireland |
16:50-17:10 | Future Directions for Research into LDL Lowering, Anti-inflammatory Drugs and Interactions ![]() |
![]() |
Sang-Hyun Kim Seoul National University, Korea |
17:10-17:20 | Panel Discussion: HyeongKyu Park, Jon Suh, Sang Chol Lee, Sang Yeop Lim |
Soon Jib Yoo(The Catholic University of Korea, Korea)
KSoLA-KSSO-KSCMS - Obesity and Atherosclerosis | |||
---|---|---|---|
13:50-14:05 | Obesity and Pathogenesis of Atherosclerosis ![]() |
![]() |
Soo Lim Seoul National University, Korea |
14:05-14:20 | Metabolically Healthy Obesity & Metabolically Unhealthy Obesity ![]() |
![]() |
Eun Jung Rhee Sungkyunkwan University, Korea |
14:20-14:35 | Fat Distribution or Amount ; What is More Important? ![]() |
![]() |
Dae Jung Kim Ajou University, Korea |
14:35-14:50 | Non-Pharmacological Treatment of Obesity ![]() |
![]() |
Mi-Kyung Kim Keimyung University, Korea |
14:50-15:05 | Pharmacological Treatment of Obesity ![]() |
![]() |
Yong-ho Lee Yonsei University, Korea |
15:05-15:20 | Panel Discussion:Chul Sik Kim, Il Suk Sohn, Jung Woo Sohn, Iksung Cho |